政协北京市第十四届委员会第四次会议期间，医疗民生成为热议焦点。多位市政协委员从互联网医疗需 求与行业规范出发，其中既提到如何推动技术落地、激活医疗数据价值，也强调明晰服务边界、防范盲 目依赖风险，既要让创新赋能，也要让规范兜底，可通过多方协同发力，形成可复制、可推广的互联网 医疗北京经验。 市政协委员王昕： 远程医疗离不开线下服务支撑 吴彬指出，平台层面，全市已审批101家互联网医院，但呈现"小散弱"特征，资源整合效能不足。优质 医疗资源层面，专家资源多"锁在医院"，仅能在本院平台提供服务，第三方平台执业受现行规定限制。 另外，监管重心仍"盯着医院"，平台责任未压实。各医疗机构信息系统形成"数据孤岛"，数据所有权、 使用权界定不清，海量医疗数据价值未被激活。 针对上述问题，吴彬提出四大针对性建议。一方面可以做强平台推动集约化发展，支持建设能整合全市 乃至更大区域资源的高水平互联网医疗平台，打造"云上医院"与实体医院协同新模式，同时探索人工智 能诊断、远程健康管理等新业态的市场化服务与收费机制，推动成熟项目逐步纳入医保。此外，要激活 数据规范开发应用，加快建立医疗数据标准规范与安全体系，在保障安全与产权的前提下 ...

Core Insights - The article discusses the implementation of a medical test result mutual recognition system in Wuhan, which allows multiple hospitals to share and recognize test results, reducing the need for repeated tests and saving time and money for patients [1][2]. Group 1: Implementation and Benefits - Wuhan has added 156 new mutual recognition projects this year, bringing the total to 436, and has achieved cross-city mutual recognition of test results within the province [1]. - Patients can now avoid unnecessary repeat tests, as doctors can access recent test results from other hospitals, streamlining the diagnostic process [2]. - For example, a patient saved 72 yuan and time by not needing to repeat a kidney function test, highlighting the practical benefits of the system [1]. Group 2: System Development and Oversight - The Wuhan Municipal Health Commission has established a "Wuhan Inspection and Test Result Mutual Recognition Platform" to facilitate the sharing of test results among public medical institutions [2]. - The city’s supervisory bodies are actively monitoring the implementation of this system to ensure efficiency and address any obstacles in data sharing [2]. - The mutual recognition system currently covers routine examination and testing projects, with plans to expand its scope to further enhance patient experience [2].

Core Points - The national medical insurance imaging cloud cross-province retrieval has officially launched, allowing more patients to enjoy convenient services when seeking medical care in different locations [1] - The National Medical Insurance Administration has promoted the "cloud" initiative for imaging data, enabling centralized storage, management, and sharing of medical imaging data across various healthcare institutions [1] - As of November 20, 24 provinces and the Xinjiang Production and Construction Corps have completed the deployment of medical insurance imaging cloud software, with 170 million indexed imaging data entries collected by the National Medical Insurance Administration [1] Industry Summary - The initiative aims to address the pain points of patients regarding repeated examinations, which are time-consuming, labor-intensive, and costly [1] - Major hospitals, such as Peking University Third Hospital and Shanghai Huashan Hospital, can now access medical imaging data from various regions, enhancing the efficiency of medical imaging across different provinces and healthcare levels [1] - The imaging data sharing will continue to expand to more provinces and healthcare institutions, facilitating high-efficiency cross-regional medical imaging flow [1]

Core Points - The "One Card, One Cloud" initiative in Shanxi aims to transform the medical treatment model by enabling health information sharing and optimizing the medical process [1][2] - The electronic health card and medical imaging cloud platform are designed to reduce the burden on patients and minimize unnecessary medical expenses [1][2] Group 1: Initiative Overview - The "One Card, One Cloud" project allows patients to access their imaging data and diagnostic reports anytime through the "Health Shanxi" official account [1] - Patients can use the electronic health card for appointment scheduling, payment, and medical record inquiries, with support for those who may not use smartphones [1] Group 2: Financial Impact - The implementation of the imaging cloud is expected to save nearly 1.4 billion yuan annually by reducing duplicate imaging tests, which currently account for 30% of all tests [2] - The initiative is projected to connect all secondary and higher public medical institutions in Shanxi by June 2026 [2] Group 3: Data Security and Future Plans - Medical imaging data will undergo desensitization before being uploaded to the cloud, with strict access management and audit tracking to ensure data security [2] - Future plans include integrating the electronic health card with medical insurance, social security cards, and financial payment systems to enhance the value of the imaging cloud platform [2]

Group 1 - The company reported a revenue of 893 million RMB and a gross profit of 331 million RMB for the six months ending June 30, 2025 [1] - Research and development expenses amounted to 26.375 million RMB [1] - The company has installed chronic disease management SaaS in 2,774 hospitals, covering 40% of the top 100 hospitals and over 20% penetration in tertiary hospitals [1] Group 2 - The company has installed pharmacy SaaS in 269,360 pharmacies, representing approximately 40% of the total pharmacies in China [1] - The company has issued over 1 billion prescriptions through its internet hospital [1] - The pharmacy SaaS allows customers, especially chronic disease patients, to access online diagnosis and prescriptions upon entering the pharmacy [1] Group 3 - The company achieved a net cash inflow from operating activities of 28.7 million RMB in the first half of the year, compared to a net cash outflow of 196 million RMB in the same period of 2024 [2] - The short-term transformation strategy focuses on P2M to achieve stable cash flow and profitability [2] - The long-term goal of the transformation is to monetize data assets and connect hospitals, pharmacies, pharmaceutical companies, patients, and payers through medical data sharing [2]

Core Viewpoint - Shanxi Province is accelerating the construction of a medical digital imaging cloud platform, enabling cross-hospital image sharing and allowing patients to access their imaging data anytime [1] Group 1: Platform Development - The platform currently connects 276 qualified public medical institutions at the secondary level and above [1] - This initiative breaks down information barriers between medical institutions, facilitating the sharing of imaging examination results [1] Group 2: Benefits and Features - The platform aims to reduce unnecessary repeat examinations and healthcare expenditures [1] - It is a crucial component of residents' electronic health records and will integrate with the electronic health card for unified access [1] - A patient-side mini-program has already been launched to enhance user experience [1] Group 3: Future Expansion - The platform will gradually extend its services to qualified grassroots medical institutions and private medical facilities [1]

Core Viewpoint - The Shanghai Financial Regulatory Bureau, in collaboration with various governmental departments, has issued measures to promote the high-quality development of commercial health insurance, aiming to support innovation in the biopharmaceutical industry [1][4]. Group 1: Measures Overview - The measures consist of five main areas and eighteen specific actions, including the construction of a multi-tiered commercial health insurance product system and the enhancement of service capabilities [1]. - There is a focus on expanding the coverage of commercial health insurance products, particularly in nursing insurance, and integrating innovative drugs and medical devices into the coverage [1][4]. Group 2: Targeted Populations - The measures encourage the development of health insurance products tailored to specific groups, such as the elderly and those with pre-existing conditions, to enhance insurance coverage for these populations [2]. - Collaboration between insurance institutions and the health industry is emphasized to improve the accessibility and affordability of innovative drugs [2]. Group 3: Service Optimization - The measures propose strengthening the health service capabilities of insurance institutions and expanding services from post-claim to proactive health management [2]. - Encouragement is given for partnerships between insurance companies and healthcare providers to enhance preventive care and chronic disease management [2]. Group 4: Innovation and Data Sharing - The measures advocate for the establishment of a "regulatory sandbox" to pilot innovative health insurance products, ensuring compliance and sustainability [3]. - There is a call for improved data sharing mechanisms among medical, insurance, and pharmaceutical sectors to support product design and risk assessment [3]. Group 5: Payment Mechanisms - The measures suggest innovating payment mechanisms for innovative drugs, involving multiple stakeholders such as insurance, charity organizations, and pharmaceutical companies [4]. - The goal is to facilitate the clinical application of innovative drugs and ensure they are included in insurance coverage without affecting basic medical insurance metrics [4].